Literature DB >> 15844191

Quantification of angiogenesis induced in rabbit cornea by breast carcinoma of women treated with tamoxifen.

Benedito Borges da Silva1, Raimundo Gerônimo da Silva Júnior, Umbelina Soares Borges, Marcos Antônio Guedes da Silveira Filho, Igor Clausius Carvalho Pimentel, Luiz Henrique Gebrim, Manuel de Jesus Simões, Edmund Chada Baracat.   

Abstract

BACKGROUND: The aim of this study was to evaluate the effect of tamoxifen on angiogenesis induced in rabbit cornea by breast carcinoma from post-menopausal women.
METHODS: Thirteen post-menopausal women with operable, estrogen receptor-positive breast carcinomas, treated with 20 mg of tamoxifen daily for 30 days prior to undergoing definitive surgery, participated in this study. Twenty-six virgin female New Zealand white rabbits, 3-4 months old, weighing approximately 2.5 kg each, were divided into two groups of 13 animals and received corneal implants of tumor either pre- or post-tamoxifen treatment. After 10 days, the animals were sacrificed, the region of the cornea between the tumor implant and the limbus was removed and quantification of angiogenesis was carried out by evaluating the entire hematoxylin-eosin stained slide, using a 10x objective lens (100x magnification). Student t-test was used in the statistical analysis of the data and statistical significance was established at P < 0.05.
RESULTS: Mean microvessel count was 106.8 +/- 5.9 pre-tamoxifen treatment and 54 +/- 5.6 post-treatment. According to Student t-test, there was a significant reduction in mean microvessel density following treatment with tamoxifen (P < 0.001).
CONCLUSIONS: Rabbit cornea proved to be an interesting experimental model for the quantification of angiogenesis. Tamoxifen, when administered for 30 days to post-menopausal women with breast cancer, significantly inhibited angiogenesis induced by tumor fragments in rabbit cornea.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844191     DOI: 10.1002/jso.20239

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases.

Authors:  Adam D Elkin; Charlotte D Jacobs
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-18       Impact factor: 4.553

2.  Mucinous Cystadenocarcinoma of the Breast with Estrogen Receptor Expression: A Case Report and Review of the Literature.

Authors:  Sema Rakıcı; Güzin Gönüllü; S Bilge Gürsel; Levent Yıldız; I Koray Bayrak; Idris Yücel
Journal:  Case Rep Oncol       Date:  2009-11-14

3.  Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women.

Authors:  B B da Silva; A R dos Santos; C G Pires; P V Lopes-Costa
Journal:  Cell Prolif       Date:  2009-05-29       Impact factor: 6.831

Review 4.  Tamoxifen non-estrogen receptor mediated molecular targets.

Authors:  Tatiana Bogush; Evgeny Dudko; Elena Bogush; Boris Polotsky; Sergei Tjulandin; Mikhail Davydov
Journal:  Oncol Rev       Date:  2012-10-04

5.  Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene.

Authors:  Benedito B da Silva; Daniel S Moita; Cleicilene G Pires; Edílson C Sousa-Junior; Alesse R dos Santos; Pedro V Lopes-Costa
Journal:  Int Semin Surg Oncol       Date:  2007-07-23

6.  Quantification of angiogenesis in estrogen receptor-positive and negative breast carcinoma.

Authors:  Jb Parentes-Vieira; Pv Lopes-Costa; Cg Pires; Ar Dos Santos; Jd Pereira-Filho; Bb da Silva
Journal:  Int Semin Surg Oncol       Date:  2007-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.